Applicant, as named in the Orange Book

Impax

Next listed expiry: Rytary on 26 Dec 2028. 2 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Rytary · 4 strengths carbidopa; levodopa	carbidopa; levodopa	203312	26 Dec 2028	patent
Crexont · 4 strengths carbidopa; levodopa	carbidopa; levodopa	217186	21 Dec 2041	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Adrenaclick · 2 strengths epinephrine	epinephrine	020800	open now	no listed protection